Oxidative Cyclization of 4-(2-Aminophenyl)-4-oxo-2-phenylbutanenitriles into 2-(3-Oxoindolin-2-ylidene)acetonitriles
- PMID: 35573208
- PMCID: PMC9089741
- DOI: 10.1021/acsomega.2c01238
Oxidative Cyclization of 4-(2-Aminophenyl)-4-oxo-2-phenylbutanenitriles into 2-(3-Oxoindolin-2-ylidene)acetonitriles
Abstract
A facile and highly efficient method for the preparation of 2-(3-oxoindolin-2-ylidene)acetonitriles from 4-(2-aminophenyl)-4-oxo-2-phenylbutanenitriles is described. The featured transformation operates via nucleophilic intramolecular cyclization and involves oxidation of the aniline moiety. Overall, this modification allowed for the improvement of yields and expansion of the reaction scope.
© 2022 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures











Similar articles
-
Unexpected cyclization of ortho-nitrochalcones into 2-alkylideneindolin-3-ones.RSC Adv. 2020 May 14;10(31):18440-18450. doi: 10.1039/d0ra03520c. eCollection 2020 May 10. RSC Adv. 2020. PMID: 35517232 Free PMC article.
-
One-Pot Synthesis of (E)-2-(3-Oxoindolin-2-ylidene)-2-arylacetonitriles.Molecules. 2022 Apr 28;27(9):2808. doi: 10.3390/molecules27092808. Molecules. 2022. PMID: 35566159 Free PMC article.
-
Synthesis of 2-Mercapto-(2-Oxoindolin-3-Ylidene)Acetonitriles from 3-(4-Chloro-5H-1,2,3-Dithiazol-5-Ylidene)Indolin-2-ones.Molecules. 2018 Jun 8;23(6):1390. doi: 10.3390/molecules23061390. Molecules. 2018. PMID: 29890669 Free PMC article.
-
A Convenient Way to Quinoxaline Derivatives through the Reaction of 2-(3-Oxoindolin-2-yl)-2-phenylacetonitriles with Benzene-1,2-diamines.Int J Mol Sci. 2022 Sep 22;23(19):11120. doi: 10.3390/ijms231911120. Int J Mol Sci. 2022. PMID: 36232422 Free PMC article.
-
Gold α-oxo carbenoids in catalysis: catalytic oxygen-atom transfer to alkynes.Angew Chem Int Ed Engl. 2011 Aug 1;50(32):7226-36. doi: 10.1002/anie.201100148. Epub 2011 Jul 1. Angew Chem Int Ed Engl. 2011. PMID: 21726021 Review.
Cited by
-
An Effective Synthesis of Previously Unknown 7-Aryl Substituted Paullones.Molecules. 2023 Mar 2;28(5):2324. doi: 10.3390/molecules28052324. Molecules. 2023. PMID: 36903571 Free PMC article.
-
Scaffold-Hopping Strategies in Aurone Optimization: A Comprehensive Review of Synthetic Procedures and Biological Activities of Nitrogen and Sulfur Analogues.Molecules. 2024 Jun 13;29(12):2813. doi: 10.3390/molecules29122813. Molecules. 2024. PMID: 38930878 Free PMC article. Review.
References
-
- Cooksey C. J. Tyrian purple: 6,6′-dibromoindigo and related compounds. Molecules 2001, 6, 736–739. 10.3390/60900736. - DOI
-
- Hoessel R.; Leclerc S.; Endicott J. A.; Nobel M. E.; Lawrie A.; Tunnah P.; Leost M.; Damiens E.; Marie D.; Marko D.; Niederberger E.; Tang W.; Eisenbrand G.; Meijer L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1999, 1, 60–67. 10.1038/9035. - DOI - PubMed
-
- Leclerc S.; Garnier M.; Hoessel R.; Marko D.; Bibb J. A.; Snyder G. L.; Greengard P.; Biernat J.; Wu Y.-Z.; Mandelkow E.-M.; Eisenbrand G.; Meijer L. Indirubins inhibit glycogen synthase kinase-3β and CDK5/P25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer’s disease. A property common to most cyclin-dependent kinase inhibitors?. J. Biol. Chem. 2001, 276, 251–260. 10.1074/jbc.M002466200. - DOI - PubMed
-
- Meijer L.; Skaltsounis A.-L.; Magiatis P.; Polychronopoulos P.; Knockaert M.; Leost M.; Ryan X. P.; Vonica C. A.; Brivanlou A.; Dajani R.; Crovace C.; Tarricone C.; Musacchio A.; Roe S. M.; Pearl L.; Greengard P. GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins. Chem. Biol. 2003, 10, 1255–1266. 10.1016/j.chembiol.2003.11.010. - DOI - PubMed
-
- Polychronopoulos P.; Magiatis P.; Skaltsounis A.-L.; Myrianthopoulos V.; Mikros E.; Tarricone A.; Musacchio A.; Roe S. M.; Pearl L.; Leost M.; Greengard P.; Meijer L. Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases. J. Med. Chem. 2004, 47, 935–946. 10.1021/jm031016d. - DOI - PubMed
LinkOut - more resources
Full Text Sources